Home  » Topic

Biocon News


Biocon Shares Gain Over 2% On Partnering With Libbs Farmaceutica
Biocon Pharma Limited, a wholly-owned subsidiary of Biocon Limited, has announced a collaboration with Libbs Farmaceutica, a leading pharmaceuticals company in Brazil, to launch generic drugs in the world's sixth most populous region. At 10 am IST, Biocon was seen trading ...
Biocon Shares Gain Over 2 On Partnering With Libbs Farmaceutica
Biocon Among Top 5 Biotech Employers In The World
On Friday, Biocon Ltd has been ranked among the top five global biotech employers for 2020 on the US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list. Ranked at number five among global pharma and biotech companies in 2020, the ...
Biocon Among Top 5 Biotech Employers In The World
This Pharma Stock Offered 65% Gains From March Lows
Kiran Mazumdar Shaw led pharma major Biocon since the March lows has reaped 65% gains, implying that if you had invested Rs. 10000 before the lockdown your money now is worth Rs. 16,500. In Monday's trade the stock struck a 52-week ...
4 Stocks In News Today
On global cues, the benchmark indices sank a huge 500 points early trade as coronavirus spread all across has darkened outlook on global economic recovery. Other market drivers are Trump's maiden visit to India as well as GDP data for October-December ...
Stocks In News Today
Biocon Biologics To Come Out With IPO Issue
On Friday, Biocon Chairperson and MD Kiran Mazumdar Shaw told a leading business channel that Biocon Biologics is looking forward to garner as much as $200-300 million via an initial public offer in next 1.5-2 years time. Also, the company ...
Biocon Hits 52-Week High After FDA Nod for Biosimilar Cancer Drug
Biocon Ltd and Mylan N.V collaboration received an approval for their biosimilar pegfilgrastim from the American regulator FDA (US Food and Drug Administration) to sell in the US market. "Fulphila is expected to be the first biosimilar pegfilgrastim available in the ...
Bluechip Pharma Stocks At 52-Week Lows: Should You Buy?
It was a disastrous week for pharma stocks, with some of the bluest names from the space hitting 52-week lows. India's largest pharma company Sun Pharma, saw its shares hit a new 52-week low of Rs 493. The country's second largest ...
Bluechip Pharma Stocks At 52 Week Lows Should You Buy
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X